Crescita Therapeutics Inc.

Crescita Therapeutics Inc.verified

CRRTF

Price:

$0.449

Market Cap:

$11.28M

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including MMPE and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination wit...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-04-11

Stock Exchange

PNK

Ticker

CRRTF

The Enterprise Value as of December 2024 (TTM) for Crescita Therapeutics Inc. (CRRTF) is 3.77M

According to Crescita Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.77M. This represents a change of 86.45% compared to the average of 2.02M of the last 4 quarters.

Crescita Therapeutics Inc. (CRRTF) Historical Enterprise Value (quarterly & annually)

How has CRRTF Enterprise Value performed in the past?

The mean historical Enterprise Value of Crescita Therapeutics Inc. over the last ten years is 7.97M. The current 3.77M Enterprise Value has changed 4.63% with respect to the historical average. Over the past ten years (40 quarters), CRRTF's Enterprise Value was at its highest in in the March 2017 quarter at 17.33M. The Enterprise Value was at its lowest in in the March 2016 quarter at -15878863.72.

Quarterly (TTM)
Annual

Average

7.97M

Median

6.03M

Minimum

1.41M

Maximum

16.24M

Crescita Therapeutics Inc. (CRRTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Crescita Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 256.08%

Maximum Annual Enterprise Value = 16.24M

Minimum Annual Increase = -87.99%

Minimum Annual Enterprise Value = 1.41M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20231.79M-74.48%
20227.03M39.84%
20215.03M256.08%
20201.41M-87.99%
201911.76M156.15%
20184.59M-2.67%
20174.72M-61.35%
201612.20M-24.87%
201516.24M8.95%

Crescita Therapeutics Inc. (CRRTF) Average Enterprise Value

How has CRRTF Enterprise Value performed in the past?

The current Enterprise Value of Crescita Therapeutics Inc. (CRRTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.62M

5-year avg

5.40M

10-year avg

7.97M

Crescita Therapeutics Inc. (CRRTF) Enterprise Value vs. Peers

How is CRRTF’s Enterprise Value compared to its peers?

Crescita Therapeutics Inc.’s Enterprise Value is greater than Amexdrug Corporation (615.36K), less than The BC Bud Corporation (7.50M), less than Aspen Pharmacare Holdings Limited (100.53B), less than Antisense Therapeutics Limited (41.46M), less than Cipher Pharmaceuticals Inc. (291.90M), less than Cannara Biotech Inc. (106.52M), less than Knight Therapeutics Inc. (509.00M), less than Lowell Farms Inc. (18.42M), greater than Canntab Therapeutics Limited (194.55K), less than Bionoid Pharma Inc. (15.17M), less than HLS Therapeutics Inc. (130.88M), greater than CENTR Brands Corp. (570.77K), greater than RAMM Pharma Corp. (529.77K), less than Craftport Cannabis Corp. (9.04B), greater than Speakeasy Cannabis Club Ltd. (2.88M), greater than City View Green Holdings Inc. (2.86M), less than RavenQuest BioMed Inc. (13.59M),

Build a custom stock screener for Crescita Therapeutics Inc. (CRRTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescita Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Crescita Therapeutics Inc. (CRRTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Crescita Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Crescita Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Crescita Therapeutics Inc. (CRRTF)?

What is the 3-year average Enterprise Value for Crescita Therapeutics Inc. (CRRTF)?

What is the 5-year average Enterprise Value for Crescita Therapeutics Inc. (CRRTF)?

How does the current Enterprise Value for Crescita Therapeutics Inc. (CRRTF) compare to its historical average?